NEW STUDY: Aluminum Adjuvants IN VACCINES REACH BRAIN
A new study adds a major link in the association of aluminum adjuvants in vaccines with neurological disorders. It demonstrates the pathway along which aluminum in vaccine adjuvants is transferred from the injection site to the brain, where it persists indefinitely. They have also identified a likely carrier and a means by which the process occurs.
Best regards,
Eileen Dannemann
Director, National Coalition of Organized Women
319 855-0307